Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Comments on CRISPR Patent Decision

February 15, 2017  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Editas breathes sigh of relief as CRISPR ruling handed down,” an article published in MedCity News.

Read the full article here

 

Related Links

Practice Areas

Industries

News & Insights

Blog - Litigation
Apr 2025
Hard to Stomach: Things You Say to Prosecute a Patent Can and Will Be Used Against You
AZURITY PHARMACEUTICALS, INC. v. ALKEM LABORATORIES LTD. Before Murphy, Moore, and Chen.  Appeal from the United States District Court for the District of Delaware. Summary: Arguments and amendments made during...
News
Mar 2025
Knobbe Martens, Partners Named Among Finalists for Inaugural Life Sciences Patent Network Awards
IRVINE, Calif., March 4, 2025 – Knobbe Martens is proud to announce that the firm and two partners have been named finalists in multiple categories at the inaugural Life Sciences...
Publications
Jan 2025
Philip Nelson Previews Upcoming Year of Key Patent Legislation in IP Watchdog Article
In the article “Legislative Developments in Patents: Prospects for the PREVAIL and RESTORE Acts and PERA in 2025,” published by IP Watchdog, partner Philip Nelson discusses three significant bills that...